These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5917942)

  • 1. Treatment of hemophilia with glycine-precipitated factor 8.
    Abildgaard CF; Simone JV; Corrigan JJ; Seeler RA; Edelstein G; Vanderheiden J; Schulman I
    N Engl J Med; 1966 Sep; 275(9):471-5. PubMed ID: 5917942
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemostatic treatment with cryoprecipitate and antifibrinolytics in a hemophilic patient subjected to tonsillectomy].
    Mancini AF; Rosito P; Paolucci G; Zanini A
    Minerva Pediatr; 1971 May; 23(19):868-75. PubMed ID: 5560087
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent experiences in treatment of hemophilic hemorrhages.
    van Creveld S; Mochtar IA; Koppe JG; Mulder E
    Isr J Med Sci; 1965 Jul; 1(4):588-93. PubMed ID: 5842272
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
    Lange D; Lazerson J
    Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
    [No Abstract]   [Full Text] [Related]  

  • 5. Home management of hemophilia A.
    Van Eys J
    J Tenn Med Assoc; 1971 May; 64(5):407-10. PubMed ID: 5091669
    [No Abstract]   [Full Text] [Related]  

  • 6. [Principles of modern therapy for hemophilia A and B in childhood].
    Ströder J; Ambs E
    Dtsch Med Wochenschr; 1968 Mar; 93(12):539-41. PubMed ID: 5639667
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.
    Shanbrom E; Thelin GM
    JAMA; 1969 Jun; 208(10):1853-6. PubMed ID: 5818829
    [No Abstract]   [Full Text] [Related]  

  • 8. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
    Duckert F; Müller G; Meili EO
    Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of hemophilia complicated by inhibitors.
    Scand J Haematol Suppl; 1980; 35():135-64. PubMed ID: 6770458
    [No Abstract]   [Full Text] [Related]  

  • 10. [The value of AHF-prophylaxis].
    Olin P
    Lakartidningen; 1968 Mar; 65(10):1031-2 passim. PubMed ID: 5720700
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rules and regulations in the therapy of hemophilia].
    Landbeck G; Kurme A
    Fortschr Med; 1972 May; 90(14):542-6. PubMed ID: 5072274
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of hemorrhage in patients with hemophilia].
    Pliushch OP; Rutberg RA; Zakhrova NS; Shefter LI
    Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):11-3. PubMed ID: 1273055
    [No Abstract]   [Full Text] [Related]  

  • 13. Substitution treatment of hemophilia a and b.
    Duckert F
    Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Substitutive treatment of hemopjolia A using a new factor VIII concentrate].
    Allain JP; Steinbuch M; Meunier L; Muller JY; Soulier JP
    Nouv Presse Med; 1976 Apr; 5(16):1047-50. PubMed ID: 1272773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired circulating anticoagulants in hemophilia A.
    Strauss HS
    N Engl J Med; 1969 Oct; 281(16):866-73. PubMed ID: 5812255
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibitors suppression in hemophilia A with continued treatment of factor VIII].
    Aznar JA; Jiménez C; García I; Martín G; Borrego D; Peiro A; Marty ML
    Sangre (Barc); 1982; 27(4A):572. PubMed ID: 6818701
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspects of the management of hemophilia in childhood. Availability of newer concentrates of antihemophilic factor failitates management.
    Strauss HS
    R I Med J; 1966 Aug; 49(8):466-8. PubMed ID: 5222119
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemophilia and related diseases, with special reference to therapeutic policy].
    Nagao T
    Nihon Rinsho; 1974 May; 32(5):993-9. PubMed ID: 4603576
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hemophilia with factor 8 concentrates.
    Dallman PR; Pool JG
    N Engl J Med; 1968 Jan; 278(4):199-202. PubMed ID: 5711341
    [No Abstract]   [Full Text] [Related]  

  • 20. Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions.
    Schimpf K; Mannucci PM; Kreutz W; Brackmann HH; Auerswald G; Ciavarella N; Mösseler J; DeRosa V; Kraus B; Brueckmann C
    N Engl J Med; 1987 Apr; 316(15):918-22. PubMed ID: 3102963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.